[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:tpm2-wt-allele":3},{"name":4,"total":5,"recruiting":5,"trials":6},"TPM2 wt Allele",11,[7,15,22,29,35,41,47,53,59,66,71],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06236139","Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:45.413021Z","2026-07-05T05:32:16.748678Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06634875","Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)",[19],"Phase 2","2026-08-26T02:19:08.084946Z","2026-05-05T02:43:28.530208Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT07182591","A Study of DS5361b in Participants With Advanced Solid Tumors",[26],"Phase 1","2026-08-26T02:15:02.712396Z","2026-05-05T02:43:27.495024Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":33,"content_modified":34},"NCT07354100","Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy",[11],"2026-08-26T02:18:52.966503Z","2026-06-17T02:29:30.060269Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT05592626","A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors",[11],"2026-08-26T02:18:05.435729Z","2026-05-05T02:43:29.329011Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT04787042","Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067",[11],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:27.747454Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[11],"2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT04706663","Precision-Based Genomics in Prostate Cancer",[],"2026-08-26T02:17:23.750999Z","2026-05-13T02:55:06.268346Z",{"nct_id":60,"title":61,"phases":62,"status":12,"updated_at":64,"content_modified":65},"NCT06622057","D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer",[63],"Phase 3","2026-08-26T02:18:26.932189Z","2026-06-14T18:39:22.251168Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":20,"content_modified":70},"NCT04198766","Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)",[11],"2026-07-30T01:46:14.442744Z",{"nct_id":72,"title":73,"phases":74,"status":12,"updated_at":75,"content_modified":76},"NCT06349642","Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform",[],"2026-08-26T02:17:03.534765Z","2026-05-13T02:55:06.483978Z"]